Previous close | 68.35 |
Open | 73.50 |
Bid | 71.85 |
Ask | 73.35 |
Strike | 260.00 |
Expiry date | 2023-06-16 |
Day's range | 72.50 - 73.50 |
Contract range | N/A |
Volume | |
Open interest | 51 |
Teladoc Health (NYSE: TDOC) sank 74% last year -- and for one particular reason. The telemedicine giant reported two billion-dollar noncash goodwill impairment charges. Both were linked to the acquisition of chronic-care specialist Livongo.
Despite being one of the few authorized COVID-19 vaccine makers in the United States, Novavax's (NVAX) vaccine struggles for market share.
An FDA advisory committee unanimously votes in favor of using the same COVID-19 vaccine strain composition for primary series and booster doses.